There's no foolproof way to know the future for Syneron Medical (Nasdaq: ELOS) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your ...

In this series, we measure how swiftly a company turns cash into goods or services and back into cash. We'll use a quick, relatively foolproof tool known as the cash conversion cycle, or CCC for short ...

IRVINE, Calif. and LONDON, April 3, 2017 /PRNewswire/ — Syneron Medical Ltd. (NASDAQ: ELOS), a leading global non-surgical aesthetic device company, and Apax Partners, a leading global private equity ...

For the quarter ended Sep. 30 (Q3), Syneron Medical missed estimates on revenues and missed estimates on earnings per share. Compared to the prior-year quarter, revenue increased and GAAP loss per ...

Syneron Medical Ltd. and Candela Corporation to Merge Creating a Leading Global Aesthetic Device Company Combination of Syneron and Candela creates the most comprehensive aesthetic device product ...

Syneron Medical (Nasdaq: ELOS) reported earnings on Feb. 9. Here are the numbers you need to know. The 10-second takeaway For the quarter ended Dec. 31 (Q4), Syneron Medical missed estimates on ...

BEIJING, March 21, 2025 /PRNewswire/ -- Syneron Bio, a cutting-edge oral macrocyclic peptide drug biotech company, announced today a strategic collaboration with the global biopharmaceutical leader ...

BEIJING, Dec. 18, 2025 /PRNewswire/ -- Syneron Bio, an macrocyclic peptide drug discovery company driven by intelligent high-throughput platform, has successfully completed its Series A and A+ ...

YOKNEAM, ISRAEL -- (MARKET WIRE) -- 11/10/2008 -- Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elos TM combined-energy medical aesthetic devices, today ...

IRVINE, Calif., May 10, 2017 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS) today announced the expiration of the 37-day "go-shop" period under the terms of the previously announced merger ...

Louis P. Scafuri, Chief Executive Officer of Syneron, commented, "During the second quarter we achieved strong financial results, including our third consecutive quarter with record revenue. Strong ...

Acquisition of Danish Ellipse adds globally renowned IPL and laser technologies to Syneron Candela's portfolio, further strengthening their position in multi-application, multi-technology devices ...